Be part of the knowledge.™

Medical Uses for Illicit Drugs: Ecstasy

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Dr. John Halpern has delivered scientific evidence supporting that MDMA, or Ecstasy, works to relieve anxiety for patients with terminal illness. Dr. Shira Johnson interviews this researcher from Harvard Medical School to learn more about altering perceptions by treating medical illnesses with illicit drugs.

John Halpern, MD

John Halpern, MD

Shira Johnson, MD

Shira Johnson, MD

Recommended

Details

Presenters

Overview
Dr. John Halpern has delivered scientific evidence supporting that MDMA, or Ecstasy, works to relieve anxiety for patients with terminal illness. Dr. Shira Johnson interviews this researcher from Harvard Medical School to learn more about altering perceptions by treating medical illnesses with illicit drugs.

John Halpern, MD

John Halpern, MD

Shira Johnson, MD

Shira Johnson, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy

Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective

IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy

IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis

A Practical Guide to Prescribing in HF

Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA

CME/CE Broadcast Replay

Pulmonary Hypertension Management: Practice Trends and Updates

Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies